摘要
95例急,慢性白血病,非何杰金淋巴瘤(NHL)和多发性骨髓瘤(MM)的S-β_2m水平在发病期和复发期均明显增高(P<0.001),在缓解期均恢复正常(P>0.05).故S-β_2m可作为观察疗效和判断预后的辅助指标。
The β_2-microglobulin level was measured in 95 cases of acute leukemia, chronic leukemia. non-Hodgkins' lymphoma and multiple myeloma. The mean value of β_2-microglobulin was increased significantly (P<0.001) in. untraeted patients and in relapse.It returned to normal level during remission. It was suggested that the determination of β_2-microglobulin provides a reliable means lor monitoring the response to treatment and prognosis.
出处
《临床血液学杂志》
CAS
1989年第3期113-114,共2页
Journal of Clinical Hematology
